Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.55 | 1.45 |
NAV | ₹82.76 | ₹100.43 |
Fund Started | 12 Jun 2007 | 08 Apr 2008 |
Fund Size | ₹35699.99 Cr | ₹63264.30 Cr |
Exit Load | Exit load of 1% if redeemed within 7 days. | Exit load of 1% if redeemed upto 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 11.35% | 11.50% |
3 Year | 16.55% | 13.61% |
5 Year | 18.02% | 17.37% |
1 Year
3 Year
5 Year
Equity | 98.15% | 92.92% |
Cash | 1.15% | 6.71% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.41% |
ICICI Bank Ltd. | 6.10% |
Reliance Industries Ltd. | 5.23% |
ITC Ltd. | 5.11% |
Infosys Ltd. | 4.48% |
State Bank of India | 3.83% |
Larsen & Toubro Ltd. | 3.64% |
Bajaj Finance Ltd. | 3.37% |
Axis Bank Ltd. | 3.28% |
GE Vernova T&D India Ltd. | 2.93% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.12% |
ICICI Bank Ltd. | 8.21% |
Larsen & Toubro Ltd. | 6.50% |
Infosys Ltd. | 4.98% |
Bharti Airtel Ltd. | 4.40% |
Reliance Industries Ltd. | 4.39% |
Ultratech Cement Ltd. | 4.17% |
Maruti Suzuki India Ltd. | 4.07% |
Axis Bank Ltd. | 3.95% |
Sun Pharmaceutical Industries Ltd. | 3.00% |
Name | Akshay Sharma | Vaibhav Dusad |
Start Date | 01 Dec 2022 | 02 May 2020 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly into equity and equity related instruments of large cap companies. | The scheme seeks to generate long term capital appreciation and income distribution to investors from a portfolio that is predominantly invested in equity and equity related securities of large cap companies. |
Launch Date | 12 Jun 2007 | 08 Apr 2008 |
Description
Launch Date